{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-018342","form_type":"8-K/A","ticker":null,"cik":"0001102942","company_name":"InnovaQor, Inc.","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.948841+00:00","generated_at":"2026-06-14T19:19:51.463249+00:00","sec_items":["1.01","3.02","5.02","5.03","5.07","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"InnovaQor names Darrell Peterson Interim CEO; insider group buys Series D preferred for $30K","bullets":["On May 14, 2023, Epizon Limited elected Gerard Dab, Justin Doherty, and Francisco Roca as directors; Sharon Hollis departed as CEO and director.","Board expanded to four; elected Darrell Peterson as director and Interim President/CEO with $10,000/month salary.","On May 12, 2023, entered Securities Purchase Agreements; each of three related parties bought 100 shares of Series D Non-Convertible Preferred for $10,000, total $30,000.","Filed Certificate of Designation authorizing 500 shares of Series D Preferred; stated value $100, no voting, dividends based on gross sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-018342","json":"https://secwatch.observer/filing/0001493152-23-018342.json","markdown":"https://secwatch.observer/filing/0001493152-23-018342.md","text":"https://secwatch.observer/filing/0001493152-23-018342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/0001493152-23-018342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T19:19:51.463249+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0613c7c887","claim":"Darrell Peterson was named as Interim President and Chief Executive Officer at InnovaQor, Inc..","evidence_excerpt":"(iv) named Mr. Peterson to be Interim President and Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/0001493152-23-018342-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"named"},{"label":"Role","value":"Interim President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"2a7ff9f7f5","claim":"Sharon Hollis departed as Director at InnovaQor, Inc..","evidence_excerpt":"Prior to the written consent by Epizon Limited, the members of the Board of Directors were Gerard Dab, Justin Doherty and Sharon Hollis.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/0001493152-23-018342-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"307606a131","claim":"Darrell Peterson was elected as Director at InnovaQor, Inc..","evidence_excerpt":"(iii) elected Darrell Peterson as a director to fill the vacancy;","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/0001493152-23-018342-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"44353911a1","claim":"Gerard Dab was elected as Chairman of the Board and Secretary at InnovaQor, Inc..","evidence_excerpt":"(i) elected Gerad Dab as Chairman of the Board and Secretary of the Company;","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/0001493152-23-018342-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Chairman of the Board and Secretary"}],"fact_type":"executive_change"},{"claim_id":"fcc57d4a9e","claim":"Francisco Roca was elected as Director at InnovaQor, Inc..","evidence_excerpt":"the following persons be elected as directors of the Company: Gerard Dab Justin Doherty Francisco Roca, III","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/0001493152-23-018342-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"60185120a567e0b0cf623220b8140dd21fbf00b6","claim":"InnovaQor, Inc.: Filed Certificate of Designation to authorize up to 500 shares of Series D Preferred Stock (effective 2023-05-12).","evidence_excerpt":"On May 12, 2023, the Company filed a Certificate of Designation with the Secretary of State of the State of Nevada to authorize the issuance of up to 500 shares of Series D Preferred Stock.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/0001493152-23-018342-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-05-12"}],"fact_type":"governance_change"},{"claim_id":"a663e487f8c13fc2e5dd721d83501c305ac8a16a","claim":"InnovaQor, Inc. entered into Purchase Agreements with Alcimede Limited, Pathlogic Limited and Hollis Capital Holdings, LLC (effective 2023-05-12).","evidence_excerpt":"On May 12, 2023, InnovaQor, Inc. (the “Company”) entered into Securities Purchase Agreements, dated as of May 12, 2023 (the “Purchase Agreements”), with Alcimede Limited (“Alcimede”), Pathlogic Limited (“Pathlogic”) and Hollis Capital Holdings, LLC (“Hollis Capital”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1102942/000149315223018342/0001493152-23-018342-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Alcimede Limited, Pathlogic Limited and Hollis Capital Holdings, LLC"},{"label":"Effective","value":"2023-05-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}